Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase kinase kinase 2 (MAP3K2), also known as MEKK2, is a serine/threonine protein kinase that plays a central role in cellular signal transduction pathways, particularly those regulating cell proliferation, differentiation, survival, and stress responses. It activates the JNK, ERK5, and NF-kappa B pathways and is implicated in multiple diseases including cancers, inflammatory disorders, fibrosis, arthritis, and immune system dysfunctions.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 2 (MEKK2).